scholarly journals Europe-wide surveillance for sexually transmitted infections: a timely and appropriate intervention

2001 ◽  
Vol 6 (5) ◽  
pp. 69-70 ◽  
Author(s):  
K. A. Fenton ◽  
J Giesecke ◽  
F F Hamers

Sexually transmitted infections (STIs), including HIV, pose a significant threat to the health and wellbeing of Europeans and require concerted and sustained intervention. Over the past decade, the number of reported cases of STIs, including antimicrobial resistant Neisseria gonorrhoeae, has increased appreciably (1), and outbreaks of syphilis have recently been reported in many Member states of the European Union (EU) (2, 3). Young people, homosexual men, and those with poor access to health care (including preventive and educational services) seem to be particularly affected, with increased travel and migration, high risk sexual behaviours, and a deterioration of public health responses to STI control (for example, partner notification) being key driving factors. Many of these demographic and behavioural trends are similar across EU states, as is the desire to develop and implement effective STI prevention and control programmes.

2021 ◽  
Vol 60 (4) ◽  
pp. 221-229
Author(s):  
Irena Klavs ◽  
Lina Berlot ◽  
Maja Milavec ◽  
Tanja Kustec ◽  
Marta Grgič-Vitek ◽  
...  

Abstract Introduction Objectives were to estimate the lifetime prevalence of self-reported sexually transmitted infections (STIs) and describe STIs healthcare. Methods Data was collected in the period 2016-2017 from a probability sample of the general population, 18-49 years old, at respondents’ homes by a combination of face-to-face interviews and self-administration of more sensitive questions. Statistical methods for complex survey data were used to account for stratification, clustered sampling, and weighting. Results Approximately every tenth sexually experienced individual reported to have had genitourinary symptoms suggestive of STIs, but only a minority of them reported to have had those respective STIs diagnosed. The proportion of sexually experienced individuals that reported to have ever been diagnosed with an STI (excluding trichomoniasis, pubic lice for men and women, and pelvic inflammatory disease, vaginal thrush, bacterial vaginosis for women) was 2.4% for men and 6.7% for women (p<0.001). Independent risk factors associated with self-reported STIs in women included at least 10 lifetime sexual partners and having been forced into sex. The majority of the last STI episodes in women were treated by gynaecologists accessible at the primary healthcare level and in men by a dermatovenerologist, after referral by a general practitioner. Approximately half of STI patients were counselled for safer sex and majority reported to have notified their sexual contacts. Conclusions Our estimates for lifetime prevalence of self-reported STIs in a probability sample of Slovenian sexually experienced men and women, 18-49 years old, indicate a substantial national burden of STIs. The results will inform national STI prevention and control policies and strategies.


2007 ◽  
Vol 5 (3) ◽  
pp. 80-91 ◽  
Author(s):  
Petra Jerman ◽  
Norman A. Constantine ◽  
Carmen R. Nevarez

Purpose: The purpose of this study was to estimate the incidence and the direct medical cost of sexually transmitted infections (STIs) among young persons in California and each of its 58 counties, and to better inform discussions about statewide policies and local resources needed for STI prevention and control efforts. Methods: On the basis of the methods developed at the Centers for Disease Control and Prevention we estimated the statewide number of new cases of eight major STIs among young persons aged 15 to 24 years in California in 2005: chlamydia, gonorrhea, syphilis, genital herpes, human papillomavirus (HPV), hepatitis B, trichomoniasis, and HIV. We also calculated the direct medical cost of these STIs using national cost-per-case estimates. To inform local policy discussions about STI control efforts, the statewide estimates were allocated by county. Results: An estimated 1.1 million new cases of STIs occurred among young persons in California in 2005, with a direct medical cost of $1.1 billion. The estimated number of new cases within counties ranged from a low of 82 in Alpine and Sierra counties, at a cost of $38,000, to a high of about 360,000 in Los Angeles County, at a cost of $390 million. Conclusions: These estimates illustrate the widespread and frequently underreported incidence and costs of youth STIs in California and its counties, and provide the foundation for a comprehensive assessment of youth STI prevention needs.


2021 ◽  
pp. 187-196
Author(s):  
Noah Kojima ◽  
J.D. Klausner

Sexually transmitted infections (STIs) refer to a broad array of pathogens that are transmitted through vaginal, anal, or oral sex. While STI case rates are highest in adolescents and young adults, the most serious health outcomes occur later in life and are disproportionately borne by women and infants. For these reasons, STI prevention and control is an important public health investment for every country. This chapter summarizes the global epidemiology of STIs and their associated health consequences, and reports on factors affecting STI spread in the community. It also discusses STI prevention and control as a public health intervention, relying on many interrelated interventions working together to reduce STI incidence and prevalence in the community. Finally, it considers some of the most likely challenges and opportunities in STI prevention anticipated over the next few decades.


2017 ◽  
Vol 28 (12) ◽  
pp. 1184-1189 ◽  
Author(s):  
Ogechukwu A Offorjebe ◽  
Adriane Wynn ◽  
Neo Moshashane ◽  
Dvora Joseph Davey ◽  
Kaitlin Arena ◽  
...  

Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) are sexually transmitted infections (STIs) associated with adverse birth outcomes. Untreated partners contribute to high rates of STI reinfection; thus, partner notification and treatment remain important components of STI care and control. A prospective cohort study was conducted among 300 pregnant women presenting to the antenatal clinic at Princess Marina Hospital in Gaborone, Botswana who enrolled in an STI screening study. Following informed consent and sample collection for CT/NG/TV testing, participants were asked if they were willing to disclose their STI result and to deliver medications to their partner(s). Those who tested positive were asked at a follow-up appointment if they notified their partners. Among the 300 participants, 294 (98%) said they would be willing to tell their partner(s) about their test results if they tested positive, and 284 (95%) said they would be willing to give their partner(s) medication if the option was available. Of those who tested positive and returned for a test of cure, 27 of 32 (84%) reported that they told their partner about the results, and 20 of 32 (63%) reported that their partner received treatment. Almost all pregnant women reported willingness to tell their partner the STI test result and give their partner medications. At test of cure, most women reported informing their partner, although actual treatment receipt was lower. Our findings suggest that pregnant women are willing to utilize patient-based partner notification, but actual partner treatment might be lower than intended.


2021 ◽  
Vol 33 ◽  
pp. 100764
Author(s):  
Patricia J. Garcia ◽  
Angelica Espinosa Miranda ◽  
Somesh Gupta ◽  
Suzanne M. Garland ◽  
María Eugenia Escobar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document